| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Epidemiology and Prevention |
Drug Discovery Program [H. Y., H-G. W.] and Clinical Investigations Program [K. B.], H. Lee Moffitt Cancer Center and Research Institute, and Department of Interdisciplinary Oncology, University of South Florida College of Medicine [H. Y., K. B., H-G. W.], Tampa, Florida 33612
Bax is a crucial mediator of the mitochondrial pathway for apoptosis, and loss of this proapoptotic Bcl-2 family protein contributes to drug resistance in human cancers. We report here that the endoplasmic reticulum Ca2+-ATPase inhibitor thapsigargin (THG) induces apoptosis of human colon cancer HCT116 cells through a Bax-dependent signaling pathway controlling the cytosolic release of mitochondrial apoptogenic molecules. Treating HCT116 cells with THG results in caspase-8 activation; Bid cleavage; Bax conformational change and mitochondrial translocation; the release of cytochrome c, Smac/Diablo, and Omi/HtrA2 into the cytosol; caspase-3 activation; and apoptosis. In contrast, knockout of Bax completely abrogates the full processing/activation of caspase-3 but has no effect on the processing of caspase-8 and the initial cleavage of caspase-3 to p24 fragment after THG treatment. The caspase-8-specific inhibitor z-IETD-fmk, as well as pan-caspase inhibitor z-VAD-fmk, but not the calpain inhibitor E-64d, prevents Bid cleavage, Bax conformational change, and subsequent caspase-3 processing and apoptosis. Caspase-8 processing is dependent on de novo protein synthesis; DR5 expression is strongly up-regulated by THG treatment. Moreover, the absence of Bax blocks THG-induced Omi and Smac release from mitochondria, and expression of cytosolic Omi (GFP-IETD-Omi) or Smac (GFP-IETD-Smac) restores the sensitivity of Bax-knockout HCT116 cells to apoptosis in response to THG treatment. Taken together, our results indicate that Bax-dependent Smac and Omi release plays an essential role in caspase-3 activation and apoptosis induced by THG in human colon cancer HCT116 cells.
This article has been cited by other articles:
|
|
 |
|
  C.-Y. Wang, Y.-S. Lin, W.-C. Su, C.-L. Chen, and C.-F. Lin Glycogen Synthase Kinase-3 and Omi/HtrA2 Induce Annexin A2 Cleavage followed by Cell Cycle Inhibition and Apoptosis Mol. Biol. Cell, October 1, 2009; 20(19): 4153 - 4161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Zhang, C. Lu, M. Whiteman, B. Chance, and J. S. Armstrong The Mitochondrial Permeability Transition Regulates Cytochrome c Release for Apoptosis during Endoplasmic Reticulum Stress by Remodeling the Cristae Junction J. Biol. Chem., February 8, 2008; 283(6): 3476 - 3486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Shankar and R. K. Srivastava Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa Carcinogenesis, June 1, 2007; 28(6): 1277 - 1286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Hussain, N. A. Al-Jomah, A. K. Siraj, P. Manogaran, K. Al-Hussein, J. Abubaker, L. C. Platanias, K. S. Al-Kuraya, and S. Uddin Sanguinarine-Dependent Induction of Apoptosis in Primary Effusion Lymphoma Cells Cancer Res., April 15, 2007; 67(8): 3888 - 3897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-M. Ham, J.-H. Lim, H.-K. Na, J.-S. Choi, B.-D. Park, H. Yim, and S.-K. Lee Ginsenoside-Rh2-Induced Mitochondrial Depolarization and Apoptosis Are Associated with Reactive Oxygen Species- and Ca2+-Mediated c-Jun NH2-Terminal Kinase 1 Activation in HeLa Cells J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1276 - 1285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Fribley, B. Evenchik, Q. Zeng, B. K. Park, J. Y. Guan, H. Zhang, T. J. Hale, M. S. Soengas, R. J. Kaufman, and C.-Y. Wang Proteasome Inhibitor PS-341 Induces Apoptosis in Cisplatin-resistant Squamous Cell Carcinoma Cells by Induction of Noxa J. Biol. Chem., October 20, 2006; 281(42): 31440 - 31447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yamaguchi and H.-G. Wang Tissue Transglutaminase Serves as an Inhibitor of Apoptosis by Cross-Linking Caspase 3 in Thapsigargin-Treated Cells Mol. Cell. Biol., January 15, 2006; 26(2): 569 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Guo, K. Rocha, P. Bali, M. Pranpat, W. Fiskus, S. Boyapalle, S. Kumaraswamy, M. Balasis, B. Greedy, E. S. M. Armitage, et al. Abrogation of Heat Shock Protein 70 Induction as a Strategy to Increase Antileukemia Activity of Heat Shock Protein 90 Inhibitor 17-Allylamino-Demethoxy Geldanamycin Cancer Res., November 15, 2005; 65(22): 10536 - 10544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Takahashi, M. Karbowski, H. Yamaguchi, A. Kazi, J. Wu, S. M. Sebti, R. J. Youle, and H.-G. Wang Loss of Bif-1 Suppresses Bax/Bak Conformational Change and Mitochondrial Apoptosis Mol. Cell. Biol., November 1, 2005; 25(21): 9369 - 9382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Obeng and L. H. Boise Caspase-12 and Caspase-4 Are Not Required for Caspase-dependent Endoplasmic Reticulum Stress-induced Apoptosis J. Biol. Chem., August 19, 2005; 280(33): 29578 - 29587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chandra, G. Choy, P. T. Daniel, and D. G. Tang Bax-dependent Regulation of Bak by Voltage-dependent Anion Channel 2 J. Biol. Chem., May 13, 2005; 280(19): 19051 - 19061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zi and A. R. Simoneau Flavokawain A, a Novel Chalcone from Kava Extract, Induces Apoptosis in Bladder Cancer Cells by Involvement of Bax Protein-Dependent and Mitochondria-Dependent Apoptotic Pathway and Suppresses Tumor Growth in Mice Cancer Res., April 15, 2005; 65(8): 3479 - 3486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Rashmi, S. Kumar, and D. Karunagaran Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL Carcinogenesis, April 1, 2005; 26(4): 713 - 723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rahmani, E. Reese, Y. Dai, C. Bauer, L. B. Kramer, M. Huang, R. Jove, P. Dent, and S. Grant Cotreatment with Suberanoylanilide Hydroxamic Acid and 17-Allylamino 17-demethoxygeldanamycin Synergistically Induces Apoptosis in Bcr-Abl+ Cells Sensitive and Resistant to STI571 (Imatinib Mesylate) in Association with Down-Regulation of Bcr-Abl, Abrogation of Signal Transducer and Activator of Transcription 5 Activity, and Bax Conformational Change Mol. Pharmacol., April 1, 2005; 67(4): 1166 - 1176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Gu, J. D. Wang, H. H.X. Xia, M. C.M. Lin, H. He, B. Zou, S. P. Tu, Y. Yang, X. G. Liu, S. K. Lam, et al. Activation of the caspase-8/Bid and Bax pathways in aspirin-induced apoptosis in gastric cancer Carcinogenesis, March 1, 2005; 26(3): 541 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yao, T.-V. V. Nguyen, and C. J. Pike {beta}-Amyloid-Induced Neuronal Apoptosis Involves c-Jun N-Terminal Kinase-Dependent Downregulation of Bcl-w J. Neurosci., February 2, 2005; 25(5): 1149 - 1158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Guo, C. Sigua, P. Bali, P. George, W. Fiskus, A. Scuto, S. Annavarapu, A. Mouttaki, G. Sondarva, S. Wei, et al. Mechanistic role of heat shock protein 70 in Bcr-Abl-mediated resistance to apoptosis in human acute leukemia cells Blood, February 1, 2005; 105(3): 1246 - 1255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Fribley, Q. Zeng, and C.-Y. Wang Proteasome Inhibitor PS-341 Induces Apoptosis through Induction of Endoplasmic Reticulum Stress-Reactive Oxygen Species in Head and Neck Squamous Cell Carcinoma Cells Mol. Cell. Biol., November 15, 2004; 24(22): 9695 - 9704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yamaguchi and H.-G. Wang CHOP Is Involved in Endoplasmic Reticulum Stress-induced Apoptosis by Enhancing DR5 Expression in Human Carcinoma Cells J. Biol. Chem., October 29, 2004; 279(44): 45495 - 45502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yamaguchi, J. Chen, K. Bhalla, and H.-G. Wang Regulation of Bax Activation and Apoptotic Response to Microtubule-damaging Agents by p53 Transcription-dependent and -independent Pathways J. Biol. Chem., September 17, 2004; 279(38): 39431 - 39437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. De Marchi, S. Campello, I. Szabo, F. Tombola, J.-C. Martinou, and M. Zoratti Bax Does Not Directly Participate in the Ca2+-induced Permeability Transition of Isolated Mitochondria J. Biol. Chem., September 3, 2004; 279(36): 37415 - 37422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Arnoult, L. M. Bartle, A. Skaletskaya, D. Poncet, N. Zamzami, P. U. Park, J. Sharpe, R. J. Youle, and V. S. Goldmacher Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria PNAS, May 25, 2004; 101(21): 7988 - 7993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Poncet, N. Larochette, A.-L. Pauleau, P. Boya, A.-A. Jalil, P.-F. Cartron, F. Vallette, C. Schnebelen, L. M. Bartle, A. Skaletskaya, et al. An Anti-apoptotic Viral Protein That Recruits Bax to Mitochondria J. Biol. Chem., May 21, 2004; 279(21): 22605 - 22614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Liu, Y. Ma, L. J. Pagliari, H. Perlman, C. Yu, A. Lin, and R. M. Pope TNF-{alpha}-Induced Apoptosis of Macrophages Following Inhibition of NF-{kappa}B: A Central Role for Disruption of Mitochondria J. Immunol., February 1, 2004; 172(3): 1907 - 1915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Dirsch, I. M. Muller, S. T. Eichhorst, G. R. Pettit, Y. Kamano, M. Inoue, J.-P. Xu, Y. Ichihara, G. Wanner, and A. M. Vollmar Cephalostatin 1 Selectively Triggers the Release of Smac/DIABLO and Subsequent Apoptosis That Is Characterized by an Increased Density of the Mitochondrial Matrix Cancer Res., December 15, 2003; 63(24): 8869 - 8876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Adams Ways of dying: multiple pathways to apoptosis Genes & Dev., October 15, 2003; 17(20): 2481 - 2495. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Fuino, P. Bali, S. Wittmann, S. Donapaty, F. Guo, H. Yamaguchi, H.-G. Wang, P. Atadja, and K. Bhalla Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B Mol. Cancer Ther., October 1, 2003; 2(10): 971 - 984. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
